Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495869 · ClinicalTrials.gov registry record
Feasibility and Validation of a Standard Phenotyping Assessment Battery
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 368
- Enrollment target
NCT03495869: Completed study, sponsored by Virginia Commonwealth University.
NCT03495869 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 368 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03495869 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 368 participants
- Enrollment target
Study Summary
The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibility of a phenotypic "fingerprint" for cohorts of individuals with addictions for use during clinical trials.
Primary Outcome
Number of dropouts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2020-03-16 |
What the finished NCT03495869 record still lists
NCT03495869 is an observational study that tracks outcomes without assigning an intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03495869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03495869 about?
NCT03495869 is a clinical study titled "Feasibility and Validation of a Standard Phenotyping Assessment Battery". The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibil...
What is the current status of trial NCT03495869?
This trial is currently completed. The enrollment target is 368 participants. The study started on 2018-06-21. Estimated completion is 2020-03-16.
Who is sponsoring clinical trial NCT03495869?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI